TAM
JAZZ icon

Todd Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Todd Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$561K Sell
2,965
-1,205
-29% -$211K 0.01% 160
2025
Q4 		$709K Sell
4,170
-47
-1% -$7.21K 0.01% 153
2025
Q3 		$556K Buy
+4,217
New +$506K 0.01% 157
2024
Q3 		– Sell
-153,054
Closed -$16.3M – 181
2024
Q2 		$16.3M Sell
153,054
-90,526
-37% -$9.95M 0.34% 132
2024
Q1 		$29.3M Buy
243,580
+73,347
+43% +$8.98M 0.6% 79
2023
Q4 		$20.9M Sell
170,233
-4,977
-3% -$621K 0.46% 101
2023
Q3 		$22.7M Sell
175,210
-1,627
-0.9% -$217K 0.54% 79
2023
Q2 		$21.9M Buy
176,837
+1,016
+0.6% +$137K 0.51% 93
2023
Q1 		$25.7M Buy
175,821
+860
+0.5% +$127K 0.62% 69
2022
Q4 		$27.9M Buy
174,961
+949
+0.5% +$139K 0.68% 57
2022
Q3 		$23.2M Buy
174,012
+170,653
+5,080% +$25.9M 0.65% 64
2022
Q2 		$524K Buy
3,359
+216
+7% +$33.3K 0.01% 193
2022
Q1 		$489K Buy
3,143
+603
+24% +$87.5K 0.01% 192
2021
Q4 		$324K Sell
2,540
-29
-1% -$3.81K 0.01% 200
2021
Q3 		$335K Sell
2,569
-20,180
-89% -$3.05M 0.01% 205
2021
Q2 		$4.04M Buy
22,749
+548
+2% +$94.9K 0.09% 147
2021
Q1 		$3.65M Buy
22,201
+1,059
+5% +$174K 0.09% 151
2020
Q4 		$3.49M Sell
21,142
-6,166
-23% -$918K 0.09% 149
2020
Q3 		$3.89M Buy
27,308
+2,244
+9% +$278K 0.12% 141
2020
Q2 		$2.77M Buy
25,064
+1,881
+8% +$208K 0.09% 152
2020
Q1 		$2.31M Buy
23,183
+20,500
+764% +$2.65M 0.09% 149
2019
Q4 		$401K Sell
2,683
-21,062
-89% -$2.87M 0.01% 194
2019
Q3 		$3.04M Buy
23,745
+21,815
+1,130% +$2.92M 0.08% 151
2019
Q2 		$275K Buy
1,930
+291
+18% +$39.1K 0.01% 208
2019
Q1 		$234K Buy
+1,639
New +$214K 0.01% 210
2017
Q3 		– Sell
-4,135
Closed -$643K – 213
2017
Q2 		$643K Sell
4,135
-2,659
-39% -$407K 0.02% 192
2017
Q1 		$986K Buy
+6,794
New +$885K 0.03% 187
2016
Q4 		– Sell
-109,419
Closed -$13.3M – 216
2016
Q3 		$13.3M Sell
109,419
-27,895
-20% -$3.76M 0.4% 112
2016
Q2 		$19.4M Buy
137,314
+3,823
+3% +$564K 0.62% 57
2016
Q1 		$17.4M Buy
133,491
+42,832
+47% +$5.33M 0.52% 77
2015
Q4 		$12.7M Sell
90,659
-24,989
-22% -$3.46M 0.39% 90
2015
Q3 		$15.4M Sell
115,648
-1,326
-1% -$228K 0.48% 67
2015
Q2 		$20.6M Buy
116,974
+11,447
+11% +$2.06M 0.56% 56
2015
Q1 		$18.2M Buy
105,527
+2,330
+2% +$400K 0.51% 59
2014
Q4 		$16.9M Buy
103,197
+435
+0.4% +$72.2K 0.47% 67
2014
Q3 		$16.5M Buy
+102,762
New +$15.8M 0.47% 66

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Todd Asset Management's JAZZ Position: Q1 2026 in Review

Todd Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 29% in Q1 2026, selling an estimated $211K and leaving 2,965 shares worth $561K. The position accounts for 0.01% of the portfolio, ranked #160.

Todd Asset Management first reported a position in JAZZ in Q3 2014 and has held it in 36 quarters since. The position peaked at $29.3M in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Todd Asset Management held 2,965 shares of Jazz Pharmaceuticals worth $561K as of Q1 2026.
  • Todd Asset Management sold 1,205 Jazz Pharmaceuticals shares in Q1 2026, an estimated $211K.
  • Jazz Pharmaceuticals made up 0.01% of Todd Asset Management's portfolio in Q1 2026, its #160 holding.
  • Todd Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2014 and has held it in 36 quarters since.
  • Todd Asset Management's Jazz Pharmaceuticals position peaked at $29.3M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Todd Asset Management's 13F filing for Q1 2026, filed 12 May 2026.